“COVAX coordinates international resources to enable low-to-middle-income countries equitable access to COVID-19 tests, therapies, and vaccines.[1] By 15 July 2020, 165 countries – representing 60% of the human population – had joined COVAX.[2]”
“However, COVAX is falling short of its goal. Despite a goal of delivering 100 million doses by the end of March 2021, as of 11 April it had delivered only 38.5 million,[3][4] and as of 17 June it had delivered only 88 million.[5]”